Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CardioComm SolutionsTSXV:EKG Median PS Value is C$0.00 as of Jul. 24, 2026. The stock has 9 warning signs investors should review. Among 262 Healthcare Providers & Services companies, CardioComm Solutions ranks worse than 381679.01% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for CardioComm Solutions's Median PS Value or its related term are showing as below:
During the past 13 years, the highest Price to Median PS Value of CardioComm Solutions was 2.67. The lowest was 0.33. And the median was 1.00.
TSXV:EKG's Price-to-Median-PS-Value is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.715 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
CardioComm Solutions (TSXV:EKG) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
CardioComm Solutions's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.01
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CardioComm Solutions Median PS Value Related Terms
CardioComm Solutions Median PS Value Historical Data
* Premium members only.
The historical data trend for CardioComm Solutions's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:EKG vs VEEV, BTSG, TEM: Median PS Value Comparison
For the Health Information Services subindustry, CardioComm Solutions's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CardioComm Solutions Price-to-Median-PS-Value vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CardioComm Solutions's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where CardioComm Solutions's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.
CardioComm Solutions's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.001.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CardioComm Solutions (TSXV:EKG) has a Median PS Value of C$0.00 as of Jul. 24, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on CardioComm Solutions and its competitors. Over the past decade, CardioComm Solutions' Median PS Value has ranged from 0.33 to 2.67. According to the industry distribution chart, CardioComm Solutions ranks #999999 out of 262 companies in the Healthcare Providers & Services industry.
Is CardioComm Solutions' Median PS Value too high?
CardioComm Solutions' current Median PS Value is C$0.00. Over the past 10 years, this metric has ranged from a low of 0.33 to a high of 2.67. Based on the distribution chart, CardioComm Solutions ranks #999999 out of 262 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does CardioComm Solutions' Median PS Value compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, CardioComm Solutions ranks #999999 out of 262 companies for Median PS Value. This places CardioComm Solutions in the lower half of its industry. The industry median Median PS Value is 0.72. Historically, CardioComm Solutions' own Median PS Value has ranged from 0.33 to 2.67 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Healthcare Providers & Services company?
The median Median PS Value among Healthcare Providers & Services companies is 0.72, based on 262 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on CardioComm Solutions and its competitors. For the Healthcare Providers & Services industry, the median Median PS Value is 0.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CardioComm Solutions's current Median PS Value is C$0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CardioComm Solutions stock overvalued right now?
CardioComm Solutions (TSXV:EKG) has a current Median PS Value of C$0.00. The current Median PS Value is C$0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For CardioComm Solutions (TSXV:EKG), the current Median PS Value is C$0.00 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CardioComm Solutions Inc develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company has one operating segment, which involves the development of software and the sale of ECG recording equipment and ECG reading services for the cardiology field. Substantially all the Company's operations, assets, and employees are in Canada. Revenue is earned in Canada and the United States. Its products are GEMS Sirona, GEMS WIN, Trident Pro 40L, HeartCheck CardiBeat - Mobile ECG Device, HeartCheck SMART Monitoring, and Others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:EKG has been successfully added to your 
